These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33093404)

  • 1. Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic.
    Bae S; McAdams-DeMarco MA; Massie AB; Ahn JB; Werbel WA; Brennan DC; Lentine KL; Durand CM; Segev DL
    Transplantation; 2021 Jan; 105(1):170-176. PubMed ID: 33093404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
    Demir E; Uyar M; Parmaksiz E; Sinangil A; Yelken B; Dirim AB; Merhametsiz O; Yadigar S; Atan Ucar Z; Ucar AR; Demir ME; Mese M; Akin EB; Garayeva N; Safak S; Oto OA; Yazici H; Turkmen A
    Transpl Infect Dis; 2020 Oct; 22(5):e13371. PubMed ID: 32657540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte-depleting induction therapy lowers the risk of acute rejection in African American pediatric kidney transplant recipients.
    Crowson CN; Reed RD; Shelton BA; MacLennan PA; Locke JE
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27699934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in recent kidney transplant recipients.
    Shingare A; Bahadur MM; Raina S
    Am J Transplant; 2020 Nov; 20(11):3206-3209. PubMed ID: 32515085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry.
    Montero C; Torres R; Benavidez C; Garcia P; Jimenez S; Yomayusa N; Gayon D; Perez J; Rosselli D; Restrepo H; Alvarez-Moreno C
    Nefrologia (Engl Ed); 2023; 43(6):757-764. PubMed ID: 36681519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplantation using lymphocyte depleting induction and standard maintenance immunosuppression at the height of the SARS-CoV-2 pandemic in New York City: A single-center experience.
    Santeusanio AD; Zendel A; Fenig Y; Mahamid A; Bhansali A; De Boccardo G; Delaney V; Farouk SS; Dunn D; Rana M; Florman S; Shapiro R
    Clin Transplant; 2020 Sep; 34(9):e14055. PubMed ID: 33439508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
    Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Pérez-Sáez MJ; Redondo-Pachón MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV
    Am J Transplant; 2020 Nov; 20(11):3140-3148. PubMed ID: 32649791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression practices during the COVID-19 pandemic: A multinational survey study of transplant programs.
    Sandal S; Boyarsky BJ; Massie A; Chiang TP; Segev DL; Cantarovich M
    Clin Transplant; 2021 Aug; 35(8):e14376. PubMed ID: 34050961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is COVID-19 infection more severe in kidney transplant recipients?
    Caillard S; Chavarot N; Francois H; Matignon M; Greze C; Kamar N; Gatault P; Thaunat O; Legris T; Frimat L; Westeel PF; Goutaudier V; Jdidou M; Snanoudj R; Colosio C; Sicard A; Bertrand D; Mousson C; Bamoulid J; Masset C; Thierry A; Couzi L; Chemouny JM; Duveau A; Moal V; Blancho G; Grimbert P; Durrbach A; Moulin B; Anglicheau D; Ruch Y; Kaeuffer C; Benotmane I; Solis M; LeMeur Y; Hazzan M; Danion F;
    Am J Transplant; 2021 Mar; 21(3):1295-1303. PubMed ID: 33259686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel coronavirus 2019 pneumonia in a kidney transplant recipient.
    Namazee N; Mahmoudi H; Afzal P; Ghaffari S
    Am J Transplant; 2020 Sep; 20(9):2599-2601. PubMed ID: 32400099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic Infections After Induction With Alemtuzumab or Basiliximab: A 3-Year Kidney Transplantation Experience.
    Florescu DF; Seaman JA; Kalil AC; Qiu F; Bremers D; Westphal SG
    Transplant Proc; 2021 Apr; 53(3):1058-1063. PubMed ID: 32921434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation.
    Toapanta N; Jiménez S; Molina-Gómez M; Maruri-Kareaga N; Llinàs-Mallol L; Villanego F; Facundo C; Rodríguez-Ferrero M; Montero N; Vázquez-Sanchez T; Gutiérrez-Dalmau A; Beneyto I; Franco A; Hernández-Vicente A; Pérez-Tamajon ML; Martin P; Ramos-Verde AM; Castañeda Z; Bestard O; Moreso F
    Clin Kidney J; 2022 Nov; 15(11):2039-2045. PubMed ID: 36320365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
    Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic.
    Lentine KL; Mannon RB; Josephson MA
    Am J Kidney Dis; 2021 May; 77(5):777-785. PubMed ID: 33388404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification in induction immunosuppression regimens to safely perform kidney transplants amid the COVID-19 pandemic: A single-center retrospective study.
    Von Stein L; Witkowsky O; Samidurai L; Doraiswamy M; Flores K; Pesavento TE; Singh P
    Clin Transplant; 2021 Aug; 35(8):e14365. PubMed ID: 34014588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
    Chen TY; Farghaly S; Cham S; Tatem LL; Sin JH; Rauda R; Ribisi M; Sumrani N
    Transpl Infect Dis; 2020 Oct; 22(5):e13378. PubMed ID: 32573882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience.
    Bossini N; Alberici F; Delbarba E; Valerio F; Manenti C; Possenti S; Econimo L; Maffei C; Pola A; Terlizzi V; Salviani C; Moscato M; Pasquali S; Zambetti N; Tonoli M; Affatato S; Pecchini P; Viola FB; Malberti F; Depetri G; Gaggiotti M; Scolari F;
    Am J Transplant; 2020 Nov; 20(11):3019-3029. PubMed ID: 32627319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.
    Nematalla AH; Bakr MA; Gheith OA; Elagroudy AE; Elshahawy el-M; Aghoneim M
    Exp Clin Transplant; 2007 Dec; 5(2):673-9. PubMed ID: 18194120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
    Phanish MK; Hull RP; Andrews PA; Popoola J; Kingdon EJ; MacPhee IAM;
    BMC Nephrol; 2020 Mar; 21(1):92. PubMed ID: 32160893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.